Novo Nordisk is reportedly facing scrutiny from the US Congress for discontinuing the sale of long-acting insulin Levemir in the US.

[Phase III clinical success of Eli Lilly ultra long-acting insulin] Eli Lilly announced that the weekly injection of ultra long-acting insulin Insulin Efstora Alfa in the treatment of type II diabete ...